Does Ohio Medicaid Cover GLP-1 Weight Loss Drugs in 2026?
Ohio Medicaid covers GLP-1 drugs for type 2 diabetes with prior authorization but excludes them for weight loss in 2026 - here's what to do.
Expert guides and comparisons for best weight loss injections.
118 articles
Ohio Medicaid covers GLP-1 drugs for type 2 diabetes with prior authorization but excludes them for weight loss in 2026 - here's what to do.
AHCCCS covers GLP-1 drugs for type 2 diabetes with prior authorization but excludes weight loss use, with narrow Wegovy exceptions for cardiovascular risk and MASH.
Iowa Medicaid covers GLP-1s for type 2 diabetes with prior authorization but excludes weight loss; Wegovy and Zepbound are covered only for CV-risk, OSA, or MASH.
Direct answer – BadgerCare and GLP-1s in 2026 Yes – as of June 2026, BadgerCare Plus and Wisconsin Medicaid cover Wegovy, Zepbound, and Saxenda for weight loss through ForwardHealth prior authorization – but approval is capped at 12 continuous months, renewal requires losing at least 5% of your starting weight, and ForwardHealth allows only two […]
Direct answer – Health First Colorado and GLP-1s in 2026 No – as of June 2026, Health First Colorado does not cover Wegovy, Zepbound, or Saxenda when prescribed only for weight loss, though it does cover GLP-1s such as Ozempic and Mounjaro for type 2 diabetes with prior authorization. Health First Colorado is the official […]
Direct answer – HUSKY Health and GLP-1s in 2026 No – as of June 2026, HUSKY Health (Connecticut Medicaid) no longer covers Wegovy, Zepbound, or Saxenda for weight loss alone; Connecticut ended GLP-1 weight-loss coverage after July 31, 2025, and instead covers the oral weight-loss medications orlistat and phentermine for members who meet BMI criteria. […]
Direct answer – TennCare and GLP-1s in 2026 Yes – as of June 2026, TennCare covers Wegovy and Zepbound for weight loss for members ages 21 and older who meet prior-authorization criteria, a major policy change that took effect August 1, 2025. TennCare requires a documented BMI of 30 or higher, or a BMI of […]
Bottom line (2026) Foundayo costs about $149/month if you self-pay — the lowest entry price of any branded GLP-1 for weight loss in 2026. If you have commercial insurance that covers it, a Lilly savings card can bring you to as little as ~$25 per fill. You can get it prescribed online through LillyDirect or […]
Bottom line (2026) For maximum weight loss, the shot still wins. Zepbound (tirzepatide injection) delivered up to 22.5% average body-weight loss at its highest dose in the SURMOUNT-1 trial, while Foundayo (orforglipron, the new oral GLP-1 pill) delivered about 11–12.4% average weight loss at its top dose in ATTAIN-1 — roughly half. But Foundayo is […]
Last updated: May 21, 2026 | Reading time: ~8 minutes | Reviewed by Dr. Marcus Tan, MD Direct answer — MassHealth and GLP-1s in 2026 Yes — MassHealth (Massachusetts Medicaid) covers some GLP-1 drugs for type 2 diabetes, including Ozempic, Mounjaro, and Trulicity, typically with prior authorization. Coverage for the weight-loss-only indications (Wegovy, Zepbound, Saxenda) […]
Last updated: May 21, 2026 | Reading time: ~9 minutes | Reviewed by Dr. Marcus Tan, MD Direct answer — Medi-Cal and GLP-1s in 2026 Partially. Medi-Cal (California Medicaid) covers GLP-1s such as Ozempic, Mounjaro, and Trulicity for type 2 diabetes, generally with prior authorization. Coverage for the weight-loss-only indications (Wegovy, Zepbound, Saxenda) is significantly […]
Last updated: May 21, 2026 | Reading time: ~16 minutes | Reviewed by Dr. Marcus Tan, MD Direct answer — Medicaid and GLP-1s in 2026 Medicaid GLP-1 coverage varies dramatically by state in 2026. Most states cover Ozempic, Mounjaro, and Trulicity for type 2 diabetes, typically with prior authorization. Coverage for the weight-loss-only indications — […]